iNeuMab™ Rat Anti-Human MINA Monoclonal Antibody (CBP2206)

Name: iNeuMab™ Rat Anti-Human MINA Monoclonal Antibody (CBP2206)
SKU: NAB201076LS
Rating: 5 (1 reviews)

[CAT#: NAB201076LS]

Anti-MINA Monoclonal Antibody

Host Species:: Rat

Species Reactivity:: Human

Applications:: WB; ICC

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Request Pricing

Inquiry

Product Overview

Immunogen

Partial recombinant protein (300-465 aa) expressed in E. coli.

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Rat

Isotype

IgG2a, κ

Clone Number

CBP2206

Applications

WB; ICC

Relevant Diseases

Brain Tumors; Alzheimer's Disease; Parkinson's Disease; Neurocutaneous Syndromes

Research Areas

Neuroinflammation

Conjugation

Unconjugated; APC; PE; HRP; Biotin; FITC

Product Properties

Form

Liquid

Formulation

PBS, pH 7.2, containing 0.09% sodium azide.

Concentration

0.5 mg/mL

Purification

Affinity chromatography

Purity

>95%, as determined by Coomassie stained SDS-PAGE.

Endotoxin Level

Low Endotoxin

Shipping

The product is shipped at 4°C. Upon receipt, store it immediately at the recommended temperature.

Storage

Store at -20°C. Upon initial thawing, apportion into working aliquots and store at -20°C. Avoid repeated freeze-thaw cycles to prevent denaturing the antibody.

Handling Advice

Store at -20°C. Upon initial thawing, apportion into working aliquots and store at -20°C. Avoid repeated freeze-thaw cycles to prevent denaturing the antibody.

Research Use Only

For research use only, not for diagnostic or therapeutic use.

Target

MINA

Official Name

KRT18

Full Name

Keratin 18

Alternative Names

KRT18; CK-18; CYK18; K18; keratin 18

Gene ID

3875 (Human); 16668 (Mouse)

Uniprot ID

P05783 (Human); P05783 (Mouse)

References

1. Thakur C, et al. 2015. Genes Cancer 6:288.
2. Pillai MR, et al. 2014. Curr. Opin. Immunol. 31:38.
3. Lian S, et al. 2013. PLoS One 8:e80638.
4. Hemmers S, et al. 2009. Nat. Immunol. 10:806.
5. Lu Y, et al. 2009. Cell Cycle. 8:2101.
6. Tsuneoka M, et al. 2004. Clin. Cancer Res. 10:7347.

Publications